# US 2010/0168040 A1 · Muscle fatigue remedy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168040 A1
- Document ID: US20100168040A1
- Status: Published application
- Kind: A1
- Application number: 12/293,722
- Filed: 2007-03-23
- Published: 2010-07-01
- Earliest claimed: 2006-03-23
- Assignees: Kyowa Hakko Kogyo Co., Ltd.
- Inventors: Miho Komatsu; Koji Morishita; Shin-ichi Hashimoto
- Web page: https://patentgrep.com/patent/US20100168040A1

## CPC

- A23L 33/18: Peptides; Protein hydrolysates
- A61K 38/05: Dipeptides
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

A muscle fatigue remedy that for persons with the symptoms of muscle pain attributed to strenuous exercise, lassitude in the arms and legs attributed to acute exercise, lower back pain and stiffness in the shoulder attributed to taking of a certain posture over a prolonged period of time, etc., relieves the symptoms and allows them to have a fulfilling life. There is provided a muscle fatigue remedy containing alanylglutamine or its salt as an active ingredient.

## Claims

### Claim 1

A muscle fatigue remedy comprising alanylglutamine or a salt thereof as an active ingredient.

### Claim 2

A method of remedying muscle fatigue, comprising the step of administering an effective amount of alanylglutamine or a salt thereof to a subject in need.

### Claim 3

A use of alanylglutamine or a salt thereof for producing a muscle fatigue remedy.

### Claim 4 (depends on 2)

The method of remedying muscle fatigue according to claim 2, wherein the alanylglutamine or salt thereof is administered in an amount of 5 mg or more and 10,000 mg or less per day.

### Claim 5 (depends on 2)

The method of remedying muscle fatigue according to claim 2, wherein the alanylglutamine or salt thereof is administered in an amount of 50 mg or more and 5,000 mg or less per day.

### Claim 6 (depends on 2)

The method of remedying muscle fatigue according to claim 2, wherein the alanylglutamine or salt thereof is administered in an amount of 500 mg or more and 3,000 mg or less per day.

### Claim 7 (depends on 2)

The method of remedying muscle fatigue according to claim 2, wherein the alanylglutamine or salt thereof is administered for a period of 1 day or more and 1 year or less.

### Claim 8 (depends on 2)

The method of remedyng muscle fatigue according to claim 2, wherein the alanylglutamine or salt thereof is administered for a period of 2 weeks or more and 3 months or less.

### Claim 9 (depends on 2)

The method of remedying muscle fatigue according to claim 2, further comprising the step of producing a sterilized aqueous preparation comprising the alanylglutamine or salt thereof, which is isotonic to the subject's blood,
wherein the administration is parenteral.

### Claim 10 (depends on 2)

The method of remedying muscle fatigue according to claim 2, further comprising the step of producing a preparation comprising the alanylglutamine or salt thereof at a concentration of 0.1% or more by weight,
wherein the administration is oral.

### Claim 11 (depends on 2)

The method of remedying muscle fatigue according to claim 2, further comprising the step of producing a preparation comprising the alanylglutamine or salt thereof at a concentration of 0.5% or more and 70% or less by weight,
wherein the administration is oral.

### Claim 12 (depends on 2)

The method of remedying muscle fatigue according to claim 2, further comprising the step of producing a preparation comprising the alanylglutamine or salt thereof at a concentration of 1% or more and 50% or less by weight,
wherein the administration is oral.
